Gainers
- TScan Therapeutics (NASDAQ:TCRX) stock rose 122.3% to $5.0 during Tuesday's regular session. The current volume of 41.6 million shares is 104202.1% of TScan Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $123.1 million.
- Novavax (NASDAQ:NVAX) stock rose 37.04% to $10.21. The current volume of 33.2 million shares is 585.1% of Novavax's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $879.8 million. The company's, Q1 earnings came out today.
- Voyager Therapeutics (NASDAQ:VYGR) stock moved upwards by 34.11% to $11.14. The current volume of 2.5 million shares is 845.4% of Voyager Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $484.9 million. As per the press release, Q1 earnings came out today.
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 32.99% to $4.58. As of 13:30 EST, Ensysce Biosciences's stock is trading at a volume of 24.8 million, which is 13244.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.8 million.
- Venus Concept (NASDAQ:VERO) stock moved upwards by 31.38% to $0.24. Trading volume for Venus Concept's stock is 3.5 million as of 13:30 EST. This is 1299.5% of its average full-day volume over the last 100 days. The company's market cap stands at $19.4 million.
- Longeveron (NASDAQ:LGVN) stock moved upwards by 28.16% to $4.05. As of 13:30 EST, Longeveron's stock is trading at a volume of 5.3 million, which is 24941.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $85.2 million.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Trevena (NASDAQ:TRVN) stock declined by 38.9% to $1.9 during Tuesday's regular session. Trevena's stock is trading at a volume of 18.9 million shares as of 13:30 EST. This is 1002.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.2 million.
- Lexaria Bioscience (NASDAQ:LEXX) stock decreased by 26.95% to $0.75. As of 13:30 EST, Lexaria Bioscience's stock is trading at a volume of 1.0 million, which is 3758.6% of its average full-day volume over the last 100 days. The company's market cap stands at $4.4 million.
- Enanta Pharma (NASDAQ:ENTA) stock fell 26.86% to $25.11. Trading volume for Enanta Pharma's stock is 607.3K as of 13:30 EST. This is 338.6% of its average full-day volume over the last 100 days. The company's market cap stands at $524.4 million. The company's, Q2 earnings came out yesterday.
- Bellicum Pharmaceuticals (NASDAQ:BLCM) stock fell 26.56% to $0.71. Bellicum Pharmaceuticals's stock is trading at a volume of 4.0 million shares as of 13:30 EST. This is 141.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.3 million.
- Coherus BioSciences (NASDAQ:CHRS) shares declined by 26.48% to $5.99. Trading volume for Coherus BioSciences's stock is 3.5 million as of 13:30 EST. This is 346.8% of its average full-day volume over the last 100 days. The company's market cap stands at $482.0 million. As per the press release, Q1 earnings came out yesterday.
- Tonix Pharmaceuticals (NASDAQ:TNXP) stock decreased by 20.42% to $0.41. Trading volume for this security as of 13:30 EST is 2.4 million, which is 222.0% of its average full-day volume over the last 100 days. The company's market cap stands at $25.3 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.